Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | lægemiddelrelateret sygdom | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | Drug | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Komplikation | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | Drug, medicament or biological substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | bivirkninger af stof | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | Substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some | 1 | |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Adverse reaction (disorder) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
bivirkning af håndkøbsmedicin | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Analgesics and nonsteroidal anti-inflammatory drug adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Diagnostic agent adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på det gastrointestinale system | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af anæstesi og medicinske gasser | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antineoplastic/immunosuppressant/immunostim adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på centralnervesystemet | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på nervesystemet | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på respirationssystemet | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemidler med primær virkning på huden | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på det muskuloskeletale system | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af chelaterende midler og antidoter | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Alternative medicines adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Miscellaneous fluids and solutions adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Miscellaneous topical preparations adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bases and inactive substances | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anti-infectives adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af vaccine, immunglobuliner og antisera | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af hormon, syntetisk hormonsubstitutionspræparat eller hormonantagonist | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af hæmatologiske midler | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Foods, vitamins, electrolytes inorganic salts adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddelgrupper med primær effekt på det kardiovaskulære system | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to premedication | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Aseptic meningitis caused by drug | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-related myocardial necrosis syndrome | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Photosensitivity caused by drug (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Polyneuropathy caused by drug (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic drug reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
medikamentelt fremkaldt glaukom | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Tetrabenazine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Griseofulvin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Amphotericin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Natamycin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Nystatin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Eruption caused by drug (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Transfusion reaction caused by toxic effect of anticoagulant (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Steroidal ecchymosis (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
ACE inhibitor-aggravated angioedema | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced mucositis (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Assessment of adverse drug reactions | Has focus | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 1 |
Adverse drug reaction prevention (procedure) | Has focus | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | 1 |
Medication side effect education (procedure) | Has focus | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af primært systemiske midler | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antihistamines | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to capillary-active drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to purine derivative diuretic | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to enzymes | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemidler til anvendelse i øjnene | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to other drugs and medicines | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to other drug or medicine NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug or medicinal substance NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning som følge af behandling af lidelse | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
lokaliseret bivirkning af administration af lægemiddel | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af antiallergisk lægemiddel | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af rette lægemiddel indgivet korrekt | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemidler med primær virkning på glatte muskler eller skeletmuskler eller respirationssystemet | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af analgetika, antipyretika og antireumatika | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Malign hypotermi forårsaget af anæstetikum | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pesticide adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced asthma | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af lægemiddel med virkning på knoglestofskiftet | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug primarily acting on nutrition | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Immunostimulant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antineoplastic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Immunosuppressant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af alkoholstofskiftemodifikator | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af dermatologisk middel til oral anvendelse | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Non-ionic surfactant adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Prostaglandin adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Terpenes adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Homoeopathic medicine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anthroposophical medicine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Herbal medicine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Fixed oil adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Lubricant adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Viscosity modifier adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sulfonamide adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af blodsukkersænkende præparat til oral anvendelse | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af kombineret kontraceptivum til oral anvendelse | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Ergoline drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Calcium regulating agent adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Iodine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Vitamin products adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Potassium adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Zinc adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Fluoride adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af medicinsk enzym | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Topical agent adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pharmaceutical fluid or solution adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic reaction to drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af surgørende midler | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af alkaliske midler | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to pyrazole derivative | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
bivirkning af bromid | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to oxytocic agents | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antineoplastic and immunosuppressive drugs NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to bromine compounds NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some |
This concept is not in any reference sets